Cardiomyocyte-specific NHE1 overexpression confers protection against myocardial infarction during hyperglycemia

Cardiovasc DiabetolPublished Mechanistic study

Authors' conclusion

Activation of myocardial NHE1 promotes MLKL autophagic degradation, mitigating cardiomyocyte necroptosis and acute hyperglycemia-exacerbated MI, highlighting NHE1 as a hyperglycemia-dependent cardioprotective target. Moderate NHE1 activation may represent a novel therapeutic strategy for MI with acute hyperglycemia.

Study context

Population
Post-MI patients (acute hyperglycemia: glucose > 7 mM in non-diabetic individuals); Myocardial infarction (MI) with acute hyperglycemia mouse models
Participants
85 post-MI patients
Methodological detailsretrospective cohort, mouse models, cardiomyocyte-specific NHE1 knockout and overexpression, RNA sequencing and drug screening
  • Retrospective cohort
  • Mouse models
  • Cardiomyocyte-specific NHE1 knockout and overexpression
  • RNA sequencing and drug screening

Main finding

As reported in the abstract

  • Acute hyperglycemia in non-diabetic post-MI patients linked to elevated BNP, CK-MB and reduced plasma Na+
  • Hyperglycemia exacerbates myocardial injury by reducing extracellular Na+, increasing intracellular Na+ and elevating pH, suggesting NHE1 activation
  • Cardiomyocyte-specific NHE1 ablation or pharmacological inhibition worsened cardiac dysfunction and fibrosis in MI with acute hyperglycemia; NHE1 overexpression conferred protection
  • Accelerated NHE1 activation via 3% NaCl and lithospermic acid mitigated cardiomyocyte necroptosis, alleviating ischemic injury in MI and ischemia reperfusion models
  • NHE1 activation promotes MLKL degradation via autophagosome-lysosomal pathways, reducing cardiomyocyte death
  • MLKL ablation counteracts the detrimental effects of NHE1 inhibition

Original publication

Cardiomyocyte-specific NHE1 overexpression confers protection against myocardial infarction during hyperglycemia. Cardiovasc Diabetol. Published 26 April 2025. doi:10.1186/s12933-025-02743-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.